Ascent Industries Co. outlined its growth strategy for its specialty chemicals business during the 17th Annual Midwest IDEAS Conference on Wednesday, emphasizing portfolio optimization and disciplined acquisition discipline. The company, which traces its roots to a 75-year-old specialty chemicals business, reported 2025 revenue of approximately $75 million, an increase of 9.2% from the prior year.
The firm’s trailing 12-month revenue reached $83.5 million, growing nearly 11% year-over-year, supported by cost optimization efforts that improved adjusted EBITDA by about $2.1 million. Ascent maintains zero debt and held cash of roughly $33 million to $35 million as of the second quarter, including $5 million in escrow expected for release. Capital expenditures have averaged about $1.5 million annually over the past four years.
Management highlighted the integration of Midwest Graphics Sales, acquired in May 2025 for $14 million in cash, as a key driver of growth. The acquisition, completed at a 7x multiple, generated $11 million in revenue and $2 million in adjusted EBITDA in 2024. Back-office and ERP integration was completed a quarter ahead of schedule, while production transfer from the Chicagoland facility is scheduled to begin in the fourth quarter of 2025 and conclude in the first quarter of 2026, ahead of the lease expiration in early April 2026.
Ascent reported a sales mix shift from 90% contract manufacturing and 10% product sales in 2023 to 65% contract manufacturing and 35% product sales in the first half of 2025. Product sales carry a 10-percentage-point margin advantage over contract manufacturing, with about 95% of raw materials sourced domestically. The company operates four assets across six plants with roughly 200 employees, maintaining current plant utilization of about 45% and targeting 70% to 80% utilization.
Gross margins are expected to reach 30% to 35% at normalized utilization, up from 21% reported in the trailing 12 months as of the second quarter of 2026. Selling, general and administrative expenses are projected near 15% of revenue at scale, with adjusted EBITDA flow-through expected to be about 15%. The company’s selling project pipeline increased by about $100 million from the first to the second quarter of 2025, with roughly half attributed to the Midwest acquisition. The 2024 conversion rate stood at 18%, with a target of 30%, and an average sales cycle of about three months.
Ascent’s market capitalization stands at roughly $140 million, with a current ratio of 4.33 and a stock beta of 0.5. The shares were trading at $15.45, up 2.45%, following a 26% return over the past year. Management reiterated a disciplined approach to acquisitions, noting that deal opportunities must align with strategic objectives.
